ENDRA Life Sciences (NDRA) P/E (2017 - 2026)
ENDRA Life Sciences (NDRA) P/E from Jun 30, 2017 to Jul 21, 2026. The TTM ENDRA Life Sciences (NDRA) P/E is -0.72. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of ENDRA Life Sciences (NDRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.72 | +30.99% |
| 2025 | -0.55 | +564.60% |
| 2024 | -0.08 | -99.48% |
| 2023 | -15.86 | -3.78% |
| 2022 | -16.48 | -68.24% |
| 2021 | -51.89 | +113.27% |
| 2020 | -24.33 | +23.63% |
| 2019 | -19.68 | +44.91% |
| 2018 | -13.58 | -91.64% |
| 2017 | -162.45 | N/A |
Comparison ENDRA Life Sciences (NDRA) P/E with competitors
ENDRA Life Sciences (NDRA) P/E is -0.72.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -245.12% |
| MBAI | CheckCap Ltd | 1.71 | -337.04% |
| FONR | Fonar Corp | 15.48 | -2242.21% |
| QGEN | Qiagen NV | 20.03 | -2872.16% |
| DGX | Quest Diagnostics Inc | 22.47 | -3210.35% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -3403.79% |
| IQV | IQVIA Holdings Inc | 25.28 | -3599.19% |
| A | Agilent Technologies Inc | 26.96 | -3831.04% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -4463.65% |
| MTD | Mettler-Toledo International Inc | 32.45 | -4591.19% |
| MEDP | Medpace Holdings Inc | 32.55 | -4604.96% |
| DHR | Danaher Corp | 38.55 | -5435.85% |
| IDXX | Idexx Laboratories Inc | 40.58 | -5715.68% |
| ILMN | Illumina Inc | 44.12 | -6206.22% |
| RVTY | Revvity Inc | 52.68 | -7391.13% |
| VCYT | Veracyte Inc | 53.71 | -7533.80% |
| ICLR | Icon Plc | 57.45 | -8051.34% |
| SHC | Sotera Health Company | 74.08 | -10353.39% |
| WAT | Waters Corp | 102.79 | -14325.72% |